Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published:May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like Nutraceuticals: exploring potential benefits and challenges of an unregulated healthcare frontier December 18, 2024 Higher participation in Specific Health Checkups associated with lower prevalence of kidney disease October 18, 2023 PacBio announces HiFi Solves, a global consortium of clinical genomics research leaders November 2, 2023
Nutraceuticals: exploring potential benefits and challenges of an unregulated healthcare frontier December 18, 2024
Higher participation in Specific Health Checkups associated with lower prevalence of kidney disease October 18, 2023
PacBio announces HiFi Solves, a global consortium of clinical genomics research leaders November 2, 2023